A picorna-like virus suppresses the N-end rule pathway to inhibit apoptosis

  1. Zhaowei Wang
  2. Xiaoling Xia
  3. Xueli Yang
  4. Xueyi Zhang
  5. Yongxiang Liu
  6. Di Wu
  7. Yuan Fang
  8. Yujie Liu
  9. Jiuyue Xu
  10. Yang Qiu
  11. Xi Zhou  Is a corresponding author
  1. Wuhan University, China
  2. Wuhan Institute of Virology, Chinese Academy of Sciences, China

Abstract

The N-end rule pathway is an evolutionarily conserved proteolytic system that degrades proteins containing N-terminal degradation signals called N-degrons, and has emerged as a key regulator of various processes. Viruses manipulate diverse host pathways to facilitate viral replication and evade antiviral defenses. However, it remains unclear if viral infection has any impact on the N-end rule pathway. Here, using a picorna-like virus as a model, we found that viral infection promoted the accumulation of caspase-cleaved Drosophila Inhibitor of Apoptosis 1 (DIAP1) by inducing the degradation of N-terminal amidohydrolase 1 (NTAN1), a key N-end rule component that identifies N-degron to initiate the process. The virus-induced NTAN1 degradation is independent of polyubiquitylation but dependent on proteasome. Furthermore, the virus-induced N-end rule pathway suppression inhibits apoptosis and benefits viral replication. Thus, our findings demonstrate that a virus can suppress the N-end rule pathway, and uncover a new mechanism for virus to evade apoptosis.

Article and author information

Author details

  1. Zhaowei Wang

    State Key Laboratory of Virology, Wuhan University, Wuhan, China
    Competing interests
    The authors declare that no competing interests exist.
  2. Xiaoling Xia

    State Key Laboratory of Virology, Wuhan University, Wuhan, China
    Competing interests
    The authors declare that no competing interests exist.
  3. Xueli Yang

    State Key Laboratory of Virology, Wuhan University, Wuhan, China
    Competing interests
    The authors declare that no competing interests exist.
  4. Xueyi Zhang

    State Key Laboratory of Virology, Wuhan University, Wuhan, China
    Competing interests
    The authors declare that no competing interests exist.
  5. Yongxiang Liu

    State Key Laboratory of Virology, Wuhan University, Wuhan, China
    Competing interests
    The authors declare that no competing interests exist.
  6. Di Wu

    State Key Laboratory of Virology, Wuhan University, Wuhan, China
    Competing interests
    The authors declare that no competing interests exist.
  7. Yuan Fang

    State Key Laboratory of Virology, Wuhan University, Wuhan, China
    Competing interests
    The authors declare that no competing interests exist.
  8. Yujie Liu

    State Key Laboratory of Virology, Wuhan University, Wuhan, China
    Competing interests
    The authors declare that no competing interests exist.
  9. Jiuyue Xu

    State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China
    Competing interests
    The authors declare that no competing interests exist.
  10. Yang Qiu

    State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China
    Competing interests
    The authors declare that no competing interests exist.
  11. Xi Zhou

    State Key Laboratory of Virology, Wuhan University, Wuhan, China
    For correspondence
    zhouxi@wh.iov.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3846-5079

Funding

National Natural Science Foundation of China (No. 31522004)

  • Xi Zhou

National Natural Science Foundation of China (No. 31600126)

  • Zhaowei Wang

Academy of Medical Sciences (No. 31761130075)

  • Xi Zhou

National Basic Research Program of China (No. 2014CB542603)

  • Xi Zhou

National High-Tech R&D Program of China (No. 2015AA020939)

  • Xi Zhou

Strategic Priority Research Program of Chinese Academy of Sciences (No. XDPB0301)

  • Xi Zhou

Natural Science Foundation of Hubei Province (No. 2016CFA045)

  • Xi Zhou

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2017, Wang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,311
    views
  • 509
    downloads
  • 17
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Zhaowei Wang
  2. Xiaoling Xia
  3. Xueli Yang
  4. Xueyi Zhang
  5. Yongxiang Liu
  6. Di Wu
  7. Yuan Fang
  8. Yujie Liu
  9. Jiuyue Xu
  10. Yang Qiu
  11. Xi Zhou
(2017)
A picorna-like virus suppresses the N-end rule pathway to inhibit apoptosis
eLife 6:e30590.
https://doi.org/10.7554/eLife.30590

Share this article

https://doi.org/10.7554/eLife.30590

Further reading

    1. Evolutionary Biology
    2. Immunology and Inflammation
    Shang Geng, Xing Lv ... Tianjun Xu
    Research Article

    The incessant arms race between viruses and hosts has led to numerous evolutionary innovations that shape life’s evolution. During this process, the interactions between viral receptors and viruses have garnered significant interest since viral receptors are cell surface proteins exploited by viruses to initiate infection. Our study sheds light on the arms race between the MDA5 receptor and 5’ppp-RNA virus in a lower vertebrate fish, Miichthys miiuy. Firstly, the frequent and independent loss events of RIG-I in vertebrates prompted us to search for alternative immune substitutes, with homology-dependent genetic compensation response (HDGCR) being the main pathway. Our further analysis suggested that MDA5 of M. miiuy and Gallus gallus, the homolog of RIG-I, can replace RIG-I in recognizing 5’ppp-RNA virus, which may lead to redundancy of RIG-I and loss from the species genome during evolution. Secondly, as an adversarial strategy, 5’ppp-RNA SCRV can utilize the m6A methylation mechanism to degrade MDA5 and weaken its antiviral immune ability, thus promoting its own replication and immune evasion. In summary, our study provides a snapshot into the interaction and coevolution between vertebrate and virus, offering valuable perspectives on the ecological and evolutionary factors that contribute to the diversity of the immune system.

    1. Chromosomes and Gene Expression
    2. Immunology and Inflammation
    Matthew C Pahl, Prabhat Sharma ... Andrew D Wells
    Research Article

    Genome-wide association studies (GWAS) have identified hundreds of genetic signals associated with autoimmune disease. The majority of these signals are located in non-coding regions and likely impact cis-regulatory elements (cRE). Because cRE function is dynamic across cell types and states, profiling the epigenetic status of cRE across physiological processes is necessary to characterize the molecular mechanisms by which autoimmune variants contribute to disease risk. We localized risk variants from 15 autoimmune GWAS to cRE active during TCR-CD28 co-stimulation of naïve human CD4+ T cells. To characterize how dynamic changes in gene expression correlate with cRE activity, we measured transcript levels, chromatin accessibility, and promoter–cRE contacts across three phases of naive CD4+ T cell activation using RNA-seq, ATAC-seq, and HiC. We identified ~1200 protein-coding genes physically connected to accessible disease-associated variants at 423 GWAS signals, at least one-third of which are dynamically regulated by activation. From these maps, we functionally validated a novel stretch of evolutionarily conserved intergenic enhancers whose activity is required for activation-induced IL2 gene expression in human and mouse, and is influenced by autoimmune-associated genetic variation. The set of genes implicated by this approach are enriched for genes controlling CD4+ T cell function and genes involved in human inborn errors of immunity, and we pharmacologically validated eight implicated genes as novel regulators of T cell activation. These studies directly show how autoimmune variants and the genes they regulate influence processes involved in CD4+ T cell proliferation and activation.